Letter: Genetic tests could keep premiums low

Mr M. A. Jones
Tuesday 30 March 1993 17:02 EST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Sir: Tom Wilkie has stimulated some correspondence concerning insurance 'When the gene is let out of the bottle' (24 March), and I thought it worth setting the record straight.

In discussing health insurance schemes in America, he attributes to UK insurers the aim of demanding applicants to supply the result of genetic testing. As he rightly says, tests for many conditions are some years away and the UK life insurance industry has no intention, within the foreseeable future, of seeking genetic tests on proposers for life, health or pensions policies.

Equally, however, where the results of such tests form part of the medical record they should be included as part of the overall assessment of the risk. It is by such careful assessment that the industry is able to accept more than 99 per cent of proposals received. If insurers were not able to seek relevant medical information, they might have to assume a worst-case scenario, with higher premiums across the board.

Genetics and its future course is a serious and complex subject, which the life insurance companies are approaching constructively.

Yours faithfully,

M. A. JONES

Chief Executive

Association of British Insurers

London, EC2

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in